wong yu liang / Shutterstock.com
The Bay Area of California has one of the greatest concentrations of life sciences companies in the world, but its biotech community is being threatened by the seemingly unstoppable rise of large technology businesses. LSIPR spoke to Christopher Stewart, chair, and Robert Eyler, vice chair, of the new North Bay Life Science Alliance to find out how it plans to strengthen the network in the area.
Since 1976, when Genentech labelled South San Francisco the “birthplace of biotechnology”, hundreds of life sciences companies have set up in the Bay Area of California to take advantage of its proximity to San Francisco and the respected academic centres nearby: the Universities of California Berkeley and San Francisco, and Stanford University.
According to the self-described custodian of the Bay Area life sciences cluster, BayBio, there are now nearly 1,000 life sciences companies in the Bay Area and Northern California, which directly and indirectly employ 125,000 people. According to BayBio, the cluster generated $13 billion in revenue in 2013 and its total market value was about $129 billion.
Abbott, Medtronic and Baxter all have bases in the Bay Area, and HIV/AIDS drug maker Gilead has its headquarters there.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
biotechnology; Medtronic; Gilead; NBLSA; BIO International Convention